|
|
|
Insider
Information: |
Schaffer Derace L |
Relationship: |
Director |
City: |
Dallas |
State: |
TX |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
6 |
|
Direct
Shares |
3,247,223 |
|
Indirect Shares
|
48,163 |
|
|
Direct
Value |
$7,001,779 |
|
|
Indirect Value
|
$88,262 |
|
|
Total
Shares |
3,295,386 |
|
|
Total
Value |
$7,090,041 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Radiologix Inc |
RGX |
Consultant |
2003-03-21 |
573,242 |
2003-03-21 |
0 |
Premium* |
|
Care Guide Inc |
CGUE |
Director |
2006-01-25 |
1,132,447 |
2004-06-17 |
12,000 |
Premium* |
|
Altimmune, Inc |
ALT |
Director |
2017-12-29 |
589,453 |
2017-12-29 |
12,393 |
Premium* |
|
American Caresource Holdings, Inc. |
ANCI |
Director |
2012-06-18 |
926,992 |
2012-06-18 |
23,770 |
Premium* |
|
King Pharmaceuticals Inc |
KG |
Director |
2011-01-31 |
0 |
2010-02-08 |
0 |
Premium* |
|
Lantheus Holdings, Inc. |
LNTH |
Director |
2020-03-03 |
25,089 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
103 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
LNTH |
Lantheus Holdings, Inc. |
Director |
|
2016-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
75,000 |
0 |
- |
|
ALT |
Altimmune, Inc |
Director |
|
2016-09-30 |
4 |
OE |
$1.45 |
$233,100 |
D/D |
130,000 |
1,023,782 |
0 |
- |
|
ALT |
Altimmune, Inc |
Director |
|
2017-01-13 |
4 |
OE |
$2.20 |
$44,000 |
D/D |
20,000 |
1,043,782 |
0 |
- |
|
LNTH |
Lantheus Holdings, Inc. |
Director |
|
2017-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
8,730 |
83,730 |
0 |
- |
|
LNTH |
Lantheus Holdings, Inc. |
Director |
|
2017-05-09 |
4 |
S |
$14.75 |
$147,500 |
D/D |
(10,000) |
73,730 |
0 |
- |
|
LNTH |
Lantheus Holdings, Inc. |
Director |
|
2017-05-10 |
4 |
S |
$15.75 |
$157,500 |
D/D |
(10,000) |
63,730 |
0 |
- |
|
LNTH |
Lantheus Holdings, Inc. |
Director |
|
2017-05-12 |
4 |
S |
$16.55 |
$82,750 |
D/D |
(5,000) |
58,730 |
0 |
- |
|
ALT |
Altimmune, Inc |
Director |
|
2017-08-21 |
4 |
B |
$2.02 |
$1,395 |
D/D |
690 |
105,068 |
2.31 |
- |
|
ALT |
Altimmune, Inc |
Director |
|
2017-08-22 |
4 |
B |
$2.10 |
$12,519 |
D/D |
5,958 |
111,026 |
2.39 |
- |
|
ALT |
Altimmune, Inc |
Director |
|
2017-08-23 |
4 |
B |
$2.22 |
$96,350 |
D/D |
43,352 |
154,378 |
2.39 |
- |
|
ALT |
Altimmune, Inc |
Director |
|
2017-08-24 |
4 |
B |
$2.24 |
$38,892 |
D/D |
17,326 |
171,704 |
2.39 |
- |
|
ALT |
Altimmune, Inc |
Director |
|
2017-08-25 |
4 |
B |
$2.25 |
$112,390 |
D/D |
50,000 |
221,704 |
2.39 |
- |
|
LNTH |
Lantheus Holdings, Inc. |
Director |
|
2017-09-12 |
4 |
S |
$17.50 |
$175,000 |
D/D |
(10,000) |
48,730 |
0 |
- |
|
LNTH |
Lantheus Holdings, Inc. |
Director |
|
2017-09-13 |
4 |
S |
$17.50 |
$87,500 |
D/D |
(5,000) |
43,730 |
0 |
- |
|
ALT |
Altimmune, Inc |
Director |
|
2017-11-17 |
4 |
B |
$2.12 |
$13,352 |
D/D |
6,295 |
227,999 |
2.39 |
- |
|
ALT |
Altimmune, Inc |
Director |
|
2017-11-20 |
4 |
B |
$2.07 |
$9,958 |
D/D |
4,800 |
232,799 |
2.39 |
- |
|
ALT |
Altimmune, Inc |
Director |
|
2017-11-21 |
4 |
B |
$2.06 |
$14,905 |
D/D |
7,236 |
240,035 |
2.39 |
- |
|
ALT |
Altimmune, Inc |
Director |
|
2017-11-22 |
4 |
B |
$2.10 |
$11,061 |
D/D |
5,261 |
245,296 |
2.39 |
- |
|
ALT |
Altimmune, Inc |
Director |
|
2017-11-24 |
4 |
B |
$2.02 |
$13,162 |
D/D |
6,505 |
251,801 |
2.39 |
- |
|
ALT |
Altimmune, Inc |
Director |
|
2017-11-27 |
4 |
B |
$2.00 |
$20,060 |
D/D |
10,042 |
261,843 |
2.39 |
- |
|
ALT |
Altimmune, Inc |
Director |
|
2017-11-28 |
4 |
B |
$1.97 |
$24,445 |
D/D |
12,395 |
274,238 |
2.39 |
- |
|
ALT |
Altimmune, Inc |
Director |
|
2017-11-29 |
4 |
B |
$1.94 |
$15,377 |
D/D |
7,942 |
282,180 |
2.39 |
- |
|
ALT |
Altimmune, Inc |
Director |
|
2017-11-30 |
4 |
B |
$1.84 |
$23,816 |
D/D |
12,978 |
295,158 |
2.39 |
- |
|
ALT |
Altimmune, Inc |
Director |
|
2017-12-01 |
4 |
B |
$1.80 |
$9,405 |
D/D |
5,215 |
300,373 |
2.39 |
- |
|
ALT |
Altimmune, Inc |
Director |
|
2017-12-04 |
4 |
B |
$1.81 |
$13,195 |
D/D |
7,300 |
307,673 |
2.39 |
- |
|
103 Records found
|
|
Page 3 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|